Reforms and consolidation to shape Japanese generics market
This article was originally published in Scrip
Executive Summary
Conducive government policy, improving public awareness and the entry of R&D-based companies into the generics segment are some of the key factors driving the expansion of Japan's generics market. Currently valued at about $2.5 billion, this is expected to double to $5 billion by 2012.